Neulasta速 in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
The purpose of this study is to estimate the relationship between patient reported outcomes (PROs) and neutropenia (or its complications) in NSCLC subjects receiving chemotherapy with or without Neulasta速 (pegfilgrastim).
Non-Small Cell Lung Cancer
DRUG: Neulasta速 (pegfilgrastim)
Quality of Life
Quality of Life, *Neutropenia, *Hospitalization, *Disease Response
The purpose of this study is to estimate the relationship between patient reported outcomes (PROs) and neutropenia (or its complications) in NSCLC subjects receiving chemotherapy with or without Neulasta速 (pegfilgrastim).